Guggenheim Capital’s uniQure QURE Stock Holding History

Guggenheim Capital’s Portfolio QURE Stock Details QURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-12,746	Closed	-$237K	–	2017
2022 Q2	$237K	Buy	+12,746	New	+$203K	﹤0.01%	1877

Other funds holding QURE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Guggenheim Capital's QURE Position: Q3 2022 in Review

Guggenheim Capital sold out of uniQure (QURE) in Q3 2022, closing a stake of 12,746 shares — an estimated $237K sold.

Guggenheim Capital first reported a position in QURE in Q2 2022 and held it in 1 quarter. The position peaked at $237K in Q2 2022. 161 funds tracked by Wall St. Rank hold QURE as of Q3 2022.

Guggenheim Capital reported no remaining uniQure position as of Q3 2022 after selling out during the quarter.
Guggenheim Capital sold 12,746 uniQure shares in Q3 2022, an estimated $237K.
Guggenheim Capital first reported a position in uniQure in Q2 2022 and held it in 1 quarter.
Guggenheim Capital's uniQure position peaked at $237K in Q2 2022.
161 funds tracked by Wall St. Rank held uniQure as of Q3 2022.

Based on Guggenheim Capital's 13F filing for Q3 2022, filed 14 Nov 2022.